Zhang, Z., Ma, Y., Guo, X., Du, Y., Zhu, Q., Wang, X., & Duan, C. (2021). FDX1 can Impact the Prognosis and Mediate the Metabolism of Lung Adenocarcinoma. Frontiers in pharmacology, 12, 749134. https://doi.org/10.3389/fphar.2021.749134
Chicago-Zitierstil (17. Ausg.)Zhang, Zeyu, Yarui Ma, Xiaolei Guo, Yingxi Du, Qing Zhu, Xiaobing Wang, und Changzhu Duan. "FDX1 Can Impact the Prognosis and Mediate the Metabolism of Lung Adenocarcinoma." Frontiers in Pharmacology 12 (2021): 749134. https://doi.org/10.3389/fphar.2021.749134.
MLA-Zitierstil (9. Ausg.)Zhang, Zeyu, et al. "FDX1 Can Impact the Prognosis and Mediate the Metabolism of Lung Adenocarcinoma." Frontiers in Pharmacology, vol. 12, 2021, p. 749134, https://doi.org/10.3389/fphar.2021.749134.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.